eicosapentaenoic acid ethyl ester has been researched along with Inflammation in 14 studies
Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Specialized pro-resolving mediator(s) (SPMs) are produced from the endogenous ω-3 polyunsaturated fatty acids (PUFA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and accelerate resolution of acute inflammation." | 5.27 | Identification of specialized pro-resolving mediator clusters from healthy adults after intravenous low-dose endotoxin and omega-3 supplementation: a methodological validation. ( Jensen, GL; Kris-Etherton, PM; Maddipati, KR; Norris, PC; Richter, CK; Riley, I; Serhan, CN; Skulas-Ray, AC, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 5 (35.71) | 2.80 |
| Authors | Studies |
|---|---|
| Bäck, M | 1 |
| Trivedi, K | 1 |
| Le, V | 1 |
| Nelson, JR | 1 |
| Simopoulos, AP | 1 |
| Serhan, CN | 3 |
| Bazinet, RP | 1 |
| Mehta, S | 1 |
| Ruth Dugas, L | 1 |
| Choo-Kang, C | 1 |
| Bovet, P | 1 |
| Forrester, T | 1 |
| Bedu-Addo, K | 1 |
| Lambert, EV | 1 |
| Plange-Rhule, J | 1 |
| Riesen, W | 1 |
| Korte, W | 1 |
| Luke, A | 1 |
| Chang, WC | 1 |
| So, J | 1 |
| Lamon-Fava, S | 1 |
| Mocking, RJT | 1 |
| Assies, J | 1 |
| Ruhé, HG | 1 |
| Schene, AH | 1 |
| Carion, TW | 1 |
| Greenwood, M | 1 |
| Ebrahim, AS | 1 |
| Jerome, A | 1 |
| Suvas, S | 1 |
| Gronert, K | 1 |
| Berger, EA | 1 |
| Peng, J | 2 |
| Zhou, Y | 1 |
| Hong, Z | 1 |
| Wu, Y | 1 |
| Cai, A | 1 |
| Xia, M | 1 |
| Deng, Z | 1 |
| Yang, Y | 1 |
| Song, T | 1 |
| Xiong, J | 1 |
| Wei, H | 1 |
| Norris, PC | 1 |
| Skulas-Ray, AC | 1 |
| Riley, I | 1 |
| Richter, CK | 1 |
| Kris-Etherton, PM | 1 |
| Jensen, GL | 1 |
| Maddipati, KR | 1 |
| Yakubu, A | 1 |
| Azlan, A | 1 |
| Loh, SP | 1 |
| Md Noor, S | 1 |
| Cawood, AL | 1 |
| Ding, R | 1 |
| Napper, FL | 1 |
| Young, RH | 1 |
| Williams, JA | 1 |
| Ward, MJ | 1 |
| Gudmundsen, O | 1 |
| Vige, R | 1 |
| Payne, SP | 1 |
| Ye, S | 1 |
| Shearman, CP | 1 |
| Gallagher, PJ | 1 |
| Grimble, RF | 1 |
| Calder, PC | 1 |
| Zampelas, A | 1 |
| Luchtman, DW | 1 |
| Meng, Q | 1 |
| Song, C | 1 |
| Poulsen, RC | 1 |
| Gotlinger, KH | 1 |
| Kruger, MC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Open-label, Single-arm Study to Evaluate the Effects of a Marine Lipid Oil Concentrate Formulation on Inflammation/Discomfort in Individuals Who Are Generally Healthy[NCT04819646] | 31 participants (Actual) | Interventional | 2021-01-07 | Completed | |||
| A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of a Specialized Pro-Resolving Mediator Formulation on Inflammation in Individuals Who Are Overweight to Mildly Obese and Otherwise Generally Healthy[NCT04269876] | 8 participants (Actual) | Interventional | 2019-10-31 | Terminated (stopped due to COVID-19 pandemic) | |||
| A Double Blind Comparison of Omacor and Placebo in Patients Awaiting Endarterectomy to Investigate the Effect on Carotid Plaque Stability[NCT00294216] | Phase 3 | 121 participants | Interventional | 2003-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for eicosapentaenoic acid ethyl ester and Inflammation
| Article | Year |
|---|---|
Icosapent ethyl in cardiovascular prevention: Resolution of inflammation through the eicosapentaenoic acid - resolvin E1 - ChemR23 axis.
Topics: Atherosclerosis; Eicosapentaenoic Acid; Humans; Inflammation | 2023 |
The case for adding eicosapentaenoic acid (icosapent ethyl) to the ABCs of cardiovascular disease prevention.
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Comorbidity; Cost-Benefit Analysis; Cytokines; Ei | 2021 |
Focus on fatty acids in the neurometabolic pathophysiology of psychiatric disorders.
Topics: Eicosapentaenoic Acid; Fatty Acids; Humans; Hypothalamo-Hypophyseal System; Inflammation; Mental Dis | 2018 |
Can Yellow Stripe Scad Compete with Salmon on Its Role in Platelet Phospholipid Membrane and Its Cardiovascular Benefits?
Topics: Adult; Animals; Anti-Inflammatory Agents; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, | 2019 |
2 trials available for eicosapentaenoic acid ethyl ester and Inflammation
8 other studies available for eicosapentaenoic acid ethyl ester and Inflammation
| Article | Year |
|---|---|
The need for precision nutrition, genetic variation and resolution in Covid-19 patients.
Topics: COVID-19; Docosahexaenoic Acids; Eicosanoids; Eicosapentaenoic Acid; Fatty Acids, Essential; Fatty A | 2021 |
Consumption of Monounsaturated Fatty Acids Is Associated with Improved Cardiometabolic Outcomes in Four African-Origin Populations Spanning the Epidemiologic Transition.
Topics: Adult; Black People; Cardiometabolic Risk Factors; Dietary Fats; Dietary Fiber; Docosahexaenoic Acid | 2021 |
Differential and shared effects of eicosapentaenoic acid and docosahexaenoic acid on serum metabolome in subjects with chronic inflammation.
Topics: Cross-Over Studies; Dietary Supplements; Docosahexaenoic Acids; Double-Blind Method; Eicosapentaenoi | 2021 |
Immunoregulatory role of 15-lipoxygenase in the pathogenesis of bacterial keratitis.
Topics: Animals; Arachidonate 15-Lipoxygenase; Eicosapentaenoic Acid; Inflammation; Inflammation Mediators; | 2018 |
Maternal eicosapentaenoic acid feeding promotes placental angiogenesis through a Sirtuin-1 independent inflammatory pathway.
Topics: Angiogenesis Inducing Agents; Animals; Diet, High-Fat; Dietary Supplements; Eicosapentaenoic Acid; F | 2019 |
Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability.
Topics: Administration, Oral; Capsules; Carotid Artery Diseases; Dietary Supplements; Docosahexaenoic Acids; | 2010 |
Ethyl-eicosapentaenoate (E-EPA) attenuates motor impairments and inflammation in the MPTP-probenecid mouse model of Parkinson's disease.
Topics: Animals; Biogenic Monoamines; Brain; Cyclooxygenase 2; Cytokines; Eicosapentaenoic Acid; Exploratory | 2012 |
Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake.
Topics: Animals; Bone Marrow; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Female; In | 2008 |